Back to Search Start Over

Downregulation of the tumour suppressor p16INK4A contributes to the polarisation of human macrophages toward an adipose tissue macrophage (ATM)-like phenotype

Authors :
Céline Cudejko
Réjane Paumelle
Lucía Fuentes
Sarah Anissa Hannou
Thérèse Hèrvée Mayi
François Pattou
Giulia Chinetti-Gbaguidi
Elena Rigamonti
Kristiaan Wouters
Bart Staels
Bruno Derudas
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 (RNMCD)
Institut Pasteur de Lille
Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)
Service de chirurgie générale et endocrinienne
Hôpital Claude Huriez [Lille]
CHU Lille-CHU Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)
Therapie Cellulaire du Diabete
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille, Droit et Santé
This work was supported by the EU FP6 grant (EIF 040851 to L. Fuentes), EU FP7 grants (PIEFGA- 2009-23522 to K. Wouters and grant no. 201608 to T. H. Mayi), an EFSD/GlaxoSmithKline Research Grant 2009 (K. Wouters and B. Staels), the Spanish Government MEC (Ministerio de Educación y Ciencia to L. Fuentes) and the Fondation pour la Recherche Médicale (DCV20070409276 to B. Staels)
Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Derudas, Marie-Hélène
Source :
Diabetologia, Diabetologia, 2011, 54 (12), pp.3150-6. ⟨10.1007/s00125-011-2324-0⟩, Diabetologia, Springer Verlag, 2011, 54 (12), pp.3150-6. ⟨10.1007/s00125-011-2324-0⟩, Diabetologia; Vol 54
Publication Year :
2011
Publisher :
HAL CCSD, 2011.

Abstract

Human adipose tissue macrophages (ATMs) display an alternatively activated (M2) phenotype, but are still able to produce excessive inflammatory mediators. However, the processes driving this particular ATM phenotype are not understood. Genome-wide association studies associated the CDKN2A locus, encoding the tumour suppressor p16(INK4A), with the development of type 2 diabetes. In the present study, p16(INK4A) levels in human ATMs and the role of p16(INK4A) in acquiring the ATM phenotype were assessed.Gene expression of p16 ( INK4A ) in ATMs was analysed and compared with that in monocyte-derived macrophages (MDMs) from obese patients or with macrophages from human atherosclerotic plaques (AMs). Additionally, p16(INK4A) levels were studied during macrophage differentiation and polarisation of monocytes isolated from healthy donors. The role of p16(INK4A) in MDMs from healthy donors was investigated by small interfering (si)RNA-mediated silencing or adenovirus-mediated overproduction of p16(INK4A).Compared with MDMs and AMs, ATMs from obese patients expressed lower levels of p16 ( INK4A ). In vitro, IL-4-induced M2 polarisation resulted in lower p16(INK4A) protein levels after differentiation of monocytes from healthy donors in macrophages. Silencing of p16(INK4A) in MDMs mediated by siRNA increased the expression of M2 marker genes and enhanced the response to lipopolysaccharide (LPS), to give a phenotype resembling that of ATM. By contrast, adenovirus-mediated overproduction of p16(INK4A) in MDMs diminished M2 marker gene expression and the response to LPS. Western blot analysis revealed that p16(INK4A) overproduction inhibits LPS- and palmitate-induced Toll-like receptor 4 (TLR4)-nuclear factor of κ light polypeptide gene enhancer in B cells (NF-κB) signalling.These results show that p16(INK4A) inhibits the acquisition of the ATM phenotype. The age-related increase in p16(INK4A) level may thus influence normal ATM function and contribute to type 2 diabetes risk.

Details

Language :
English
ISSN :
0012186X and 14320428
Database :
OpenAIRE
Journal :
Diabetologia, Diabetologia, 2011, 54 (12), pp.3150-6. ⟨10.1007/s00125-011-2324-0⟩, Diabetologia, Springer Verlag, 2011, 54 (12), pp.3150-6. ⟨10.1007/s00125-011-2324-0⟩, Diabetologia; Vol 54
Accession number :
edsair.doi.dedup.....532c01f6c2364f0759e25d792296b93e